303 lead form fill jobs found

Your Quest Career. Seek it Out. We are an industry leader with a longstanding reputation for exceptional quality and stability in our market. We inspire action. We illuminate answers. We advocate better health.

A global life sciences and healthcare company seeking answers We believe in harnessing science for human good. And so we work day and night, around the world, to deliver answers for all your health questions—because we know that knowledge has the potential to make life better for all. WHAT WE DO We’re in the business of health answers. We tackle almost every known health challenge—from commonly understood and emerging viruses to life-threatening conditions and very rare diseases.  Our integrated approach means we’re able to see each idea through, full circle. Our work has helped to power clearer, more confident decisions for those dealing with some of life’s most critical choices. It’s why we promise to bring solutions to market with speed and precision—because every answer is paramount.

A global life sciences and healthcare company seeking answers We believe in harnessing science for human good. And so we work day and night, around the world, to deliver answers for all your health questions—because we know that knowledge has the potential to make life better for all. WHAT WE DO We’re in the business of health answers. We tackle almost every known health challenge—from commonly understood and emerging viruses to life-threatening conditions and very rare diseases.  Our integrated approach means we’re able to see each idea through, full circle. Our work has helped to power clearer, more confident decisions for those dealing with some of life’s most critical choices. It’s why we promise to bring solutions to market with speed and precision—because every answer is paramount.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.